G03AA07 • levonorgestrel + ethinyl estradiol • Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations
The combination of levonorgestrel and ethinylestradiol is used as an oral contraceptive to prevent pregnancy. Levonorgestrel is a progestin, and ethinylestradiol is an estrogen, both working to inhibit ovulation and alter the uterine lining.
The medication is taken orally, usually once daily at the same time, following a 21- or 28-day cycle. It is important to adhere to the administration schedule to ensure contraceptive effectiveness.
Side effects may include nausea, headaches, breast tenderness, or mood changes. In rare cases, severe reactions such as venous thromboembolism may occur.
This combination is not recommended for pregnant women, breastfeeding mothers, or patients with a history of thrombosis, severe liver disease, or hypersensitivity to any of the components.
Substance: levonorgestrel + ethinyl estradiol
Date of last drug list: 01-06-2025
Commercial code: W61877001
Concentration: 150mcg / 30mcg / 10mcg
Pharmaceutical form: tablets
Quantity: 84
Product type: original
Price: 119.78 RON
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: TEVA OPERATIONS POLAND SP. Z.O.O. - POLONIA
Holder: THERAMEX IRELAND LIMITED - IRLANDA
Number: 12865/2019/01
Shelf life: 3 years